Nzs Capital, LLC Repligen Corp Transaction History
Nzs Capital, LLC
- $2.31 Billion
- Q1 2024
A detailed history of Nzs Capital, LLC transactions in Repligen Corp stock. As of the latest transaction made, Nzs Capital, LLC holds 81,522 shares of RGEN stock, worth $9.79 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
81,522
Previous 82,476
1.16%
Holding current value
$9.79 Million
Previous $14.8 Million
1.11%
% of portfolio
0.65%
Previous 0.8%
Shares
4 transactions
Others Institutions Holding RGEN
# of Institutions
522Shares Held
53.2MCall Options Held
1.05MPut Options Held
228K-
Black Rock Inc. New York, NY7.77MShares$933 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$612 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$428 Million0.08% of portfolio
-
State Street Corp Boston, MA1.76MShares$211 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.46MShares$176 Million0.31% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.66B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....